The correlation of asparaginase enzyme activity levels after PEG ‐asparaginase administration with clinical characteristics and adverse effects in Chinese paediatric patients with acute lymphoblastic leukaemia
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19605 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Cai Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology, Fujian Medical University, Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Asparaginase, Polyethylene Glycols, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Young and Middle-aged Scientist Program of Fujian Provincial Health Care Commission, Fujian Provincial Clinical Research Center for Hematological Malignancies, Fujian Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Studies on asparaginase enzyme activity (AEA) monitoring in Chinese patients receiving PEG‐asparaginase remain limited. We monitored AEA in paediatric patients diagnosed with acute lymphoblastic leukaemia (ALL) and treated according to the Chinese Children's Cancer Group study protocols, CCCG‐ALL‐2015/CCCG‐ALL‐2020 protocols. We measured the AEA at days 7 ± 1 and 14 ± 1 and analysed their association with patient characteristics and PEG‐asparaginase‐related adverse effects (AEs). We measured 2147 samples from 329 patients. Mean AEA levels (interquartile range) were 931 iu/L (654–1174 iu/L) at day 7 ± 1 and 664 iu/L (463–860 iu/L) at day 14 ± 1. The AEA levels were higher in younger children and increased with the cumulative dose numbers. PEG‐asparaginase inactivation rate was 19.1%, and the silent inactivation (SI) rate was 12.5%. Nine patients were identified with allergic‐like reactions. Hypofibrinogenaemia, hypertriglyceridaemia, pancreatitis and thrombosis were associated with older age, whereas hypoglycaemia was associated with younger age. The risk of hypertriglyceridaemia and hypoglycaemia increased with cumulative dose numbers of PEG‐asparaginase. Except for hypofibrinogenaemia, elevated AEA levels did not increase the risk of PEG‐asparaginase‐related AEs. Drug monitoring can be utilized as guidance for treatment decision‐making. Individualizing asparaginase doses do not reduce toxicities. The treatment target of PEG‐asparaginase remains to achieve sustained and adequate activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology, Fujian Medical University, Union Hospital, Fuzhou, China.
- Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
ORCID-Profile: Cai Chen, Shaohua Le
Förderung
- Young and Middle-aged Scientist Program of Fujian Provincial Health Care Commission
- Fujian Provincial Clinical Research Center for Hematological Malignancies
- Fujian Provincial Natural Science Foundation of China
- National Key Clinical Specialty Discipline Construction Program of China
- Natural Science Foundation of Fujian Province
Zitieren
APA
Chen, C., Li, J., Chen, Y., Gao, Q., Li, N., & Le, S. (2024). The correlation of asparaginase enzyme activity levels after PEG ‐asparaginase administration with clinical characteristics and adverse effects in Chinese paediatric patients with acute lymphoblastic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.19605
Vancouver
Chen C, Li J, Chen Y, Gao Q, Li N, Le S. The correlation of asparaginase enzyme activity levels after PEG ‐asparaginase administration with clinical characteristics and adverse effects in Chinese paediatric patients with acute lymphoblastic leukaemia. British Journal of Haematology. 2024. doi:10.1111/bjh.19605
BibTeX
@article{Chen2024,
author = {Chen, Cai and Li, Jian and Chen, Yiqiao and Gao, Qinli and Li, Nainong and Le, Shaohua},
title = {The correlation of asparaginase enzyme activity levels after PEG ‐asparaginase administration with clinical characteristics and adverse effects in Chinese paediatric patients with acute lymphoblastic leukaemia},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19605}
}
EUVIMED